TCL Archive Intarferon Results Promising, ACS Says, And commits Another $3.4 Million February 22, 1980
TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004
